Cost and cost-effectiveness in asthma - Use of pharmacoeconomics to assess the value of asthma interventions

Immunology and Allergy Clinics of North America

Volumn 16, Issue 4, 1996, Pages 819-839

  Sullivan, S D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; SALBUTAMOL; SALMETEROL;

ASTHMA; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; PHARMACOECONOMICS; PRIORITY JOURNAL; REVIEW;

EID: 0030472467     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70274-5     Document Type: Article

References (48)

1. E. Adelroth S. Thompson Advantages of high-dose inhaled budesonide Lancet 1 1988 476
2. H.D. Banta B.R. Luce Health Care Technology and Its Assessment 1993 Oxford University Press New York
3. P.J. Barnes S. Pedersen Efficacy and safety of inhaled corticosteroids in asthma Am Rev Respir Dis 148 1993 S1 S26
4. M.B. Bolton B.C. Tilley J. Kuder The cost and effectiveness of an education program for adults who have asthma J Gen Intern Med 6 1991 401 407
5. Boston Consulting Group The Costs of Asthma in the Federal Republic of Germany 1995 The Boston Consulting Group Boston
6. L.P. Boulet K.R. Chapman L.W. Green J.M. FitzGerald Asthma education Chest 106 suppl 4 1994 184S 196S
7. L.M. Campbell R.J. Simpson M.L. Turbitt A comparison of the cost-effectiveness of budesonide 400 μg/day and 800 μg/day in the management of mild-to-moderate asthma in general practice Br J Med Econ 6 1993 67 74
8. N.M. Clark C.H. Feldman D. Evans The impact of health education on frequency and cost of health care use by low income children with asthma J Allergy Clin Immunol 78 1986 108 115
9. T.J.H. Clark The Occurrence and Cost of Asthma 1990 Cambridge Medical Publications West Sussex, UK
10. G.J. Connett W. Lenney S.M. McConchie The cost-effectiveness of budesonide in severe asthmatics aged one to three years Br J Med Econ 6 1993 127 134
11. M.F. Drummond G.L. Stoddart G.W. Torrance Methods for the Economic Evaluation of Health Care Programmes 1987 Oxford University Press New York
12. J.M. Eisenberg Clinical economics: A guide to economic analysis of clinical practices JAMA 262 1989 2879 2886
13. P. Ellwood Outcomes management: A technology of patient experience N Engl J Med 318 1988 1549 1556
14. C.L. Emerman R.K. Cydulka D. Effron A randomized, controlled comparison of isoetharine and albuterol in the treatment of acute asthma Ann Emerg Med 20 1991 1090 1093
15. P. Fireman G.A. Friday C. Gira Teaching self-management skills to asthmatic children and their parents in an ambulatory care setting Pediatrics 68 1981 341 348
16. U.G. Gerdtham P. Hertzman G. Boman Impact of Inhaled Corticosteroids on Asthma Hospitalization in Sweden: A Pooled Regression Analysis 1993 Research Report of the Ekonomiska Forskningsinstitutet, Center for Health Economics, Stockholm School of Economics Stockholm
17. Grampian Asthma Study of Integrated Care (GRASSIC) Integrated care for asthma: A clinical, social, and economic evaluation BMJ 308 1994 559 564
18. L.W. Green Toward cost-benefit evaluations of health education: Some concepts, methods, and examples Health Educ Monog 2 1974 34 64
19. D.A. Grimes Technology follies: The uncritical acceptance of medical innovation JAMA 269 1993 3030 3033
20. A.C. Jasper Z. Mohsenifar S. Kahan Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients Chest 91 1987 614 618
21. M. Johannesson M.C. Weinstein Designing and conducting cost-benefit analyses B. Spilker Quality of Life and Pharmacoeconomics in Clinical Trials ed 2 1996 Lippincott-Raven Publishers Philadelphia
22. N.C. Karalus A.C. Harrison Inhaled high-dose beclomethasone in chronic asthma N Z Med J 100 1987 306 308
23. M.D. Krahn C. Berka P. Langlois A.S. Detsky Direct and indirected costs of asthma in Canada, 1990 Can Med Assoc J 154 1990 821 831
24. A. Laupacis D. Feeny A.S. Detsky P.X. Tugwell How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations Can Med Assoc J 146 1992 473 481
25. C.E. Lewis G. Rachelefsky M.A. Lewis A randomized trial of ACT (asthma care training) for kids Pediatrics 74 1984 478 486
26. B. Littenburg E.H. Gluck A controlled trial of methylprednisolone in the emergency treatment of acute asthma N Engl J Med 314 1986 150 152
27. C.M. Mellis J.K. Peak A.E. Bauman A.J. Woolcock The cost of asthma in New South Wales Med J Aust 155 1991 522 528
28. I. Muhlhauser B. Richter D. Kraut Evaluation of a structured treatment and teaching programme on asthma J Intern Med 230 1991 157 164
29. National Asthma Campaign Report on the Cost of Asthma in Australia 1992 National Asthma Campaign
30. National Heart, Lung, and Blood Institute Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma 1991 US Department of Health and Human Services Bethesda NIH publication No. 91-3042
31. B.J.C. Perera Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country Arch Dis Child 73 1995 312 316
32. T.P. Rees B. Lennox A.P. Timney Comparison of increasing the dose of budesonide to 800 μg/day with a maintained dose of 400 μg/day in mild to moderate asthmatic patients Eur J Clin Res 4 1993 67 77
33. R.N. Ross M. Morris S.R. Sakowitz B.A. Berman Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: A retrospective, record-based study Clin Ther 10 1988 188 203
34. M.P. Rutten-van Mölken E.K. Van Doorslaer M.C. Jansen Cost-effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma PharmacoEconomics 4 1993 257 270
35. M.P. Rutten-van Mölken E.K. Van Doorslaer M.C. Jansen Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 151 1995 975 982
36. M. Sculpher M.J. Buxton The episode-free day as a composite measure of effectiveness Pharmacoeconomics 4 1993 345 352
37. B. Sondergaard F. Davidsen B. Kirkeby The economics of an intensive education program for asthmatic patients: A prospective controlled trial PharmacoEconomics 1 1992 207 212
38. W. Summer R. Elston L. Tharpe Aerosol bronchodilator delivery methods: Relative impact on pulmonary function and cost of respiratory care Arch Intern Med 149 1989 618 623
39. S. Thompson On the social cost of asthma Eur J Respir Dis 136 1984 185 191
40. J.C. Tierce W. Meller B. Berlow W.C. Gerth Assessing the cost of albuterol inhalers in the Michigan and California Medicaid programs: A total cost-of-care approach Clin Ther 11 1989 53 61
41. G.W. Torrance Measurement of health state utilities for economic appraisal: A review J Health Econ 5 1986 1 30
42. C. Trautner B. Richter M. Berger Cost-effectiveness of a structured treatment and teaching programme on asthma Eur Respir J 6 1993 1485 1491
43. J. von Neumann O. Morgenstern Theory of Games and Economic Behaviour 1994 Princeton University Press Princeton
44. K.E. Warner B.R. Luce Cost-Benefit and Cost-effectiveness Analysis in Health Care: Principles, Practice, and Potential 1982 Health Administration Press Ann Arbor, MI
45. M.C. Weinstein W.B. Stason Foundations of cost-effectiveness analysis for health and medical practices N Engl J Med 296 1977 716 721
46. K.B. Weiss P.J. Gergen T.A. Hodgson An economic evaluation of asthma in the United States N Engl J Med 326 1992 862 866
47. K.B. Weiss S.D. Sullivan The economic costs of asthma: A review and conceptual model PharmacoEconomics 4 1993 14 30
48. R.A. Windsor W.C. Bailey J.M. Richards Jr Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma Am J Public Health 80 1990 1519 1521